| Total | Group 1 (PTB) (n= 48) | Group 2 (LTB) (n= 42) | Group 3 (CT) (n= 40) | p-value |
Age (years) | 35 ± 12.5 | 29 ± 9.25 | 32 ± 11.23 | 26 ± 8.65 | 0.865 |
Gender Male Female |
|
|
|
|
|
| 94 (72.3%) 36 (27.7%) | 42 (87.5%) 6 (12.5%) | 31 (73.8%) 11 (26.2%) | 21 (52.5%) 19 (47.5%) | 0.0254 |
Duration of illness Median (Min-Max) | 9 (4 - 15) | 10 (3-25) | 11 (6 - 20) | - | 0.906 |
Pulmonary function parameters |
|
|
|
|
|
FEV1 (L) | 2.36 ± 0.54 | 1.99 ± 0.82 | 2.34 ± 0.74 | 2.76 ± 0.42 | 0.219 |
FVC (L) | 2.87 ± 0.75 | 2.76 ± 1.06 | 2.90 ± 0.95 | 3.30 ± 0.52 | 0.002 |
FEV1/FCV ratio (%) | 79.72 ± 8.64 | 74.21 ± 17.29 | 81.57 ± 9.64 | 83.63 ± 4.75 | 0.036 |
PEFR (L/min) | 265.62 | 212 ± 51.81 | 256± 38.07 | 329 ± 74.21 | 0.493 |